Home > Research > Browse

Results for inflammation

Publications & Outputs

  1. Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells

    Hammond, J., Maher, B. A., Gonet, T., Bautista, F. & Allsop, D., 14/09/2022, In: Antioxidants. 11, 9, 18 p., 1814.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  2. Reduced cutaneous CD200:CD200R1 signaling in psoriasis enhances neutrophil recruitment to skin

    Linley, H., Jaigirdar, S., Mohamed, K., Griffiths, C. E. M. & Saunders, A., 31/07/2022, In: Immunity, Inflammation and Disease. 10, 7, 14 p., e648.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. The response of macrophages and their osteogenic potential modulated by micro/nano-structured Ti surfaces

    Liu, W., Liang, L., Liu, B., Zhao, D., Tian, Y., Huang, Q. & Wu, H., 30/09/2021, In: Colloids and Surfaces B: Biointerfaces. 205, 11 p., 111848.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  4. Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.

    Reich, N. & Hölscher, C., 14/12/2020, In: Frontiers in Neuroscience. 14, 35 p., 614828.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  5. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

    Yuan, Z., Li, D., Feng, P., Xue, G., Ji, C., Li, G. & Hölscher, C., 5/10/2017, In: European Journal of Pharmacology. 812, p. 82-90 9 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  6. Investigating dysbiosis as a cause and predictor of intestinal pathology

    Beamish, E., 2017, Lancaster University. 256 p.

    Research output: ThesisDoctoral Thesis

  7. Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases

    Pouget, J. G., Gonçalves, V. F., Spain, S. L., Finucane, H. K., Raychaudhuri, S., Kennedy, J. L., Knight, J. & Schizophrenia Working Group of the Psychiatric Genomics Consortium, 09/2016, In: Schizophrenia Bulletin. 42, 5, p. 1176-1184 9 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  8. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology

    Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H. & Gomez-Nicola, D., 1/03/2016, In: Brain. 139, 3, p. 891-907 17 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  9. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat

    Han, L., Holscher, C., Xue, G., Li, G. & Li, D., 6/01/2016, In: NeuroReport. 27, 1, p. 23-32 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  10. The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

    Worthington, J. J., 3/08/2015, In: Biochemical Society Transactions. 43, 4, p. 727-733 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  11. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability

    Alhamoruni, A., Wright, K., Larvin, M. & O'Sullivan, S. E., 04/2012, In: British Journal of Pharmacology. 165, 8, p. 2598-610 13 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

More results »